These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 24779913)
1. Combined inhibition of caspase 3 and caspase 7 by two highly selective DARPins slows down cellular demise. Flütsch A; Ackermann R; Schroeder T; Lukarska M; Hausammann GJ; Weinert C; Briand C; Grütter MG Biochem J; 2014 Jul; 461(2):279-90. PubMed ID: 24779913 [TBL] [Abstract][Full Text] [Related]
2. Specific inhibition of caspase-3 by a competitive DARPin: molecular mimicry between native and designed inhibitors. Schroeder T; Barandun J; Flütsch A; Briand C; Mittl PR; Grütter MG Structure; 2013 Feb; 21(2):277-89. PubMed ID: 23333429 [TBL] [Abstract][Full Text] [Related]
3. Specific targeting of human caspases using designed ankyrin repeat proteins. Flütsch A; Schroeder T; Barandun J; Ackermann R; Bühlmann M; Grütter MG Biol Chem; 2014 Oct; 395(10):1243-52. PubMed ID: 25153593 [TBL] [Abstract][Full Text] [Related]
4. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation. Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of new fluorinated, 2-substituted 5-pyrrolidinylsulfonyl isatin derivatives as caspase-3 and caspase-7 inhibitors: nonradioactive counterparts of putative PET-compatible apoptosis imaging agents. Limpachayaporn P; Schäfers M; Schober O; Kopka K; Haufe G Bioorg Med Chem; 2013 Apr; 21(7):2025-36. PubMed ID: 23411396 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of N-acyl-substituted 1,2-benzisothiazol-3-one derivatives as caspase-3 inhibitors. Li Z; Pan Y; Zhong W; Zhu Y; Zhao Y; Li L; Liu W; Zhou H; Yang C Bioorg Med Chem; 2014 Dec; 22(24):6735-45. PubMed ID: 25468037 [TBL] [Abstract][Full Text] [Related]
7. Design, construction, and characterization of a second-generation DARP in library with reduced hydrophobicity. Seeger MA; Zbinden R; Flütsch A; Gutte PG; Engeler S; Roschitzki-Voser H; Grütter MG Protein Sci; 2013 Sep; 22(9):1239-57. PubMed ID: 23868333 [TBL] [Abstract][Full Text] [Related]
8. Designed ankyrin repeat proteins (DARPins) as novel isoform-specific intracellular inhibitors of c-Jun N-terminal kinases. Parizek P; Kummer L; Rube P; Prinz A; Herberg FW; Plückthun A ACS Chem Biol; 2012 Aug; 7(8):1356-66. PubMed ID: 22568706 [TBL] [Abstract][Full Text] [Related]
9. Isatin sulfonamides: potent caspases-3 and -7 inhibitors, and promising PET and SPECT radiotracers for apoptosis imaging. Limpachayaporn P; Schäfers M; Haufe G Future Med Chem; 2015; 7(9):1173-96. PubMed ID: 26132525 [TBL] [Abstract][Full Text] [Related]
10. Selective detection and inhibition of active caspase-3 in cells with optimized peptides. Vickers CJ; González-Páez GE; Wolan DW J Am Chem Soc; 2013 Aug; 135(34):12869-76. PubMed ID: 23915420 [TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria. Zhang XD; Zhang XY; Gray CP; Nguyen T; Hersey P Cancer Res; 2001 Oct; 61(19):7339-48. PubMed ID: 11585775 [TBL] [Abstract][Full Text] [Related]
12. Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis. Seol DW; Li J; Seol MH; Park SY; Talanian RV; Billiar TR Cancer Res; 2001 Feb; 61(3):1138-43. PubMed ID: 11221844 [TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio. Mühlethaler-Mottet A; Flahaut M; Bourloud KB; Auderset K; Meier R; Joseph JM; Gross N BMC Cancer; 2006 Aug; 6():214. PubMed ID: 16930472 [TBL] [Abstract][Full Text] [Related]
14. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells. Shi RX; Ong CN; Shen HM Cancer Res; 2005 Sep; 65(17):7815-23. PubMed ID: 16140950 [TBL] [Abstract][Full Text] [Related]
15. Selective detection of caspase-3 versus caspase-7 using activity-based probes with key unnatural amino acids. Vickers CJ; González-Páez GE; Wolan DW ACS Chem Biol; 2013 Jul; 8(7):1558-66. PubMed ID: 23614665 [TBL] [Abstract][Full Text] [Related]
16. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells. Sylvester PW; Shah S Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643 [TBL] [Abstract][Full Text] [Related]
18. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells. Sun SY; Yue P; Hong WK; Lotan R Cancer Res; 2000 Dec; 60(24):7149-55. PubMed ID: 11156424 [TBL] [Abstract][Full Text] [Related]
19. ATM kinase promotes both caspase-8 and caspase-9 activation during TNF-α-induced apoptosis of HeLa cells. Liu L; Yim H; Choi JH; Kim ST; Jin Y; Lee SK FEBS Lett; 2014 Mar; 588(6):929-35. PubMed ID: 24530529 [TBL] [Abstract][Full Text] [Related]
20. Identification of FDA-approved drugs as novel allosteric inhibitors of human executioner caspases. Krishna Deepak RNV; Abdullah A; Talwar P; Fan H; Ravanan P Proteins; 2018 Nov; 86(11):1202-1210. PubMed ID: 30194780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]